Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
26.27
-0.53 (-1.98%)
At close: Apr 28, 2026, 4:00 PM EDT
26.39
+0.12 (0.44%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Forte Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 12.41 | 15.41 | 10.62 | 8.3 | 7.63 | |
| Research & Development | 58.25 | 21.19 | 21.86 | 5.59 | 13.85 | |
| Operating Expenses | 70.66 | 36.6 | 32.49 | 13.9 | 21.49 | |
| Operating Income | -70.66 | -36.6 | -32.49 | -13.9 | -21.49 | |
| Interest & Investment Income | 2.72 | 1.31 | 1.12 | 0.16 | - | |
| Other Non Operating Income (Expenses) | -0.4 | -0.19 | -0.11 | -0.15 | -0.22 | |
| EBT Excluding Unusual Items | -68.34 | -35.48 | -31.48 | -13.88 | -21.71 | |
| Pretax Income | -68.34 | -35.48 | -31.48 | -13.88 | -21.71 | |
| Income Tax Expense | 1.04 | - | - | - | - | |
| Net Income | -69.38 | -35.48 | -31.48 | -13.88 | -21.71 | |
| Net Income to Common | -69.38 | -35.48 | -31.48 | -13.88 | -21.71 | |
| Shares Outstanding (Basic) | 15 | 3 | 1 | 1 | 1 | |
| Shares Outstanding (Diluted) | 15 | 3 | 1 | 1 | 1 | |
| Shares Change (YoY) | 404.74% | 130.90% | 81.61% | 24.45% | 89.81% | |
| EPS (Basic) | -4.71 | -12.17 | -24.92 | -19.96 | -38.85 | |
| EPS (Diluted) | -4.71 | -12.17 | -24.92 | -19.96 | -38.85 | |
| Free Cash Flow | -51 | -30.78 | -28.79 | -8.19 | -16.68 | |
| Free Cash Flow Per Share | -3.46 | -10.56 | -22.80 | -11.77 | -29.85 | |
| EBITDA | -70.59 | -36.56 | -32.48 | -13.86 | -21.45 | |
| D&A For EBITDA | 0.06 | 0.04 | 0.01 | 0.04 | 0.04 | |
| EBIT | -70.66 | -36.6 | -32.49 | -13.9 | -21.49 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.